z-logo
open-access-imgOpen Access
Disease-free Probability and Triple-Negative Breast Cancer
Author(s) -
Prakasit Chirappapha,
Thongchai Sukarayothin,
Yodying Wasuthit,
Ronnarat Suvikapalornkul,
Panuwat Lertsithichai,
Youwanush Kongdan
Publication year - 2012
Publication title -
ramathibodi medical journal
Language(s) - English
Resource type - Journals
ISSN - 2651-0561
DOI - 10.33165/rmj.2012.35.1.117663
Subject(s) - triple negative breast cancer , medicine , breast cancer , estrogen receptor , oncology , progesterone receptor , pathological , cancer , distant metastasis , triple negative , metastasis , stage (stratigraphy) , disease , biology , paleontology
Objective: To compare the probabilities of local recurrence and distant metastasis between women with triple-negative and non- triple negative breast cancers. Methods: Medical and pathological records of breast cancer patients treated between the years 2002 and 2006 were reviewed. Results: There were 256 patients with complete data on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expression determinations. There were 54 patients (21%) with triple-negative (ER-, PR-, HER2 -) cancers. Triple-negative patients were more likely to have larger tumors with higher histologic grade. The median fallow-up time was 4 years. The probabilities of local and distant recurrence were similar between the two groups of patients. Only two factors were independently and significantly associated with overall recurrence: tumor stage and tumor size. Conclusion: Triple-negative breast cancer did not have a higher risk for both local recurrence and distant metastasis when compared with non-triple negative cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom